Location: West Hollywood, CA
CIK: 0001704132 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 28, 2020
Total Value: $81.14M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | Cytokinetics Incorporated | 2,177,292 | $25.67M | 31.6% | $8.13 | +57.0% | COM | 23282W605 |
| — | Myokardia, Inc. | 307,400 | $14.41M | 17.8% | $47.61 | — | COM | 62857M105 |
| FULC | Fulcrum Therapeutics, Inc. | 998,655 | $11.92M | 14.7% | $11.06 | +44.6% | COM | 359616109 |
| INSM | Insmed Incorporated | 678,322 | $10.87M | 13.4% | $26.85 | -11.7% | COM | 457669307 |
| — | Biohaven Pharmaceutical Holding Company Ltd. | 156,355 | $5.321M | 6.6% | $34.03 | — | COM | G11196105 |
| VYGR | Voyager Therapeutics, Inc. | 516,751 | $4.728M | 5.8% | $21.95 | — | COM | 92915B106 |
| — | Aerie Pharmaceuticals, Inc. | 227,717 | $3.074M | 3.8% | $24.60 | — | COM | 00771V108 |
| — | bluebird bio, Inc. | 50,000 | $2.298M | 2.8% | $45.96 | — | COM | 09609G100 |
| — | Kiniksa Pharmaceuticals, Ltd. | 65,000 | $1.006M | 1.2% | $15.48 | — | COM | G5269C101 |
| KURA | Kura Oncology, Inc. | 93,000 | $925K | 1.1% | $13.91 | -17.7% | COM | 50127T109 |
| QURE | uniQure N.V. | 19,082 | $905K | 1.1% | $57.46 | 0.0% | SHS | N90064101 |